L.I.F.E. Program (Lifestyle, Food & Exercise) begins Thursday, Aug.12, to Sept. 30, 7 to 9 p.m. Whether you are simply seeking to lose unwanted weight or need a dietary / health makeover, the L.I.F.E. program is for you!

BANGALORE: Pharmaceutical and biotechnology major Wockhardt has received final approval from the United States Food & Drug Administration (US FDA) for marketing 25mg, 50mg, 100mg and 200mg extended-release tablets of Metoprolol succinate, a cardiac drug.

Pharmaceutical and biotechnology major, Wockhardt has received final approval from the United States Food & Drug Administration for marketing the cardiac drug.

Pharmaceutical and biotechnology major, Wockhardt has received final approval from the United States Food & Drug Administration (US FDA) for marketing the 25mg, 50mg, 100mg and 200mg extended-release tablets of metoprolol succinate which is used for 24-hour control of hypertension, treatment of angina and in improvement of survival after heart attack. metoprolol succinate is the generic name for ...

67 WALL STREET, New York - July 19, 2010 - The Wall Street Transcript has recently published its Biotechnology & Pharmaceuticals Report offering a timely review of the sector to serious investors and industry executives. This special feature contains expert industry commentary through in-depth interviews with public company CEOs, Equity Analysts and Money Managers. The full issue is available by ...